“…Since then, many papers have provided increasing evidence supporting a central role for BMP6 in the control of iron homeostasis. The main findings of some of these studies are briefly summarized in here (for a more extensive review see [92,93]]: i) HJV knock out mouse presents impaired BMP signaling [91]; ii) HJV knock out mice livers have low phospho Smad1,5, 8 activity [91], iii) HJV binds directly to BMP ligands, mainly BMP2, BMP4 and BMP6, being BMP6 the ligand with higher affinity, as demonstrated by both in vitro and ex vivo experiments [55,94]; iv) BMP ligands enhance hepcidin expression at the transcriptional level as hepcidin promoter have two BMP responsive elements [26,91,[94][95][96]; v) BMP2 and BMP6 administration in mice increases hepcidin expression levels in liver and decreases plasma iron [94,97]; vi) Conversely, administration of dorsomorphin (an ALK2, ALK3 and ALK6 inhibitor) or HJV.fc (acting as ligand trap) in mice decreases the expression of hepatic hepcidin and increases plasma iron [94,98]; vii) Hepatic BMP6 levels are regulated by iron levels in vivo [99]. An increase in BMP6 serum levels is observed after short-and longterm iron overload [55]; viii) Iron overload phenotype observed in BMP6 null mice resembles the phenotype of HJV knock out mice [97,100]; ix) BMP6 is produced and secreted into portal circulation by enterocytes of small intestinal villus tips in response to iron absorption [55]; x) ALK2 and ALK3 BMP type I receptors appear to be involved in mediating BMP6 signaling in liver [101].…”